Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir

BACKGROUND & AIM: The resistance profile of anti-hepatitis C virus (HCV) agents used in combination is important to guide optimal treatment regimens. We evaluated baseline and treatment-emergent NS3/4A and NS5B amino-acid variants among HCV genotype (GT)-1a and -1b-infected patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Kristi L., Sarrazin, Christoph, Nelson, David R., Scherer, Joseph, Sha, Nanshi, Marquis, Martin, Côté-Martin, Alexandra, Vinisko, Richard, Stern, Jerry O., Mensa, Federico J., Kukolj, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975400/
https://www.ncbi.nlm.nih.gov/pubmed/27494410
http://dx.doi.org/10.1371/journal.pone.0160668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975400/
https://www.ncbi.nlm.nih.gov/pubmed/27494410
http://dx.doi.org/10.1371/journal.pone.0160668

Ejemplares similares